Ark Therapeutics Buys Finland’s Lymphatix

LONDON (Thomson Financial) - Ark Therapeutics Group PLC said it is buying Helsinki-based company Lymphatix Oy for 2.25 mln eur in shares.
MORE ON THIS TOPIC